secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2024-06-28T23:59:59+00:00
Accession:  0001493152-24-025598
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma shareholders authorize capital reduction, elect directors, reject officer liability amendment
--------------------------------------------------------------------------------

- Shareholders approved reducing authorized capital to 100M common + 1M preferred shares; amendment effective June 27, 2024.
- Six directors elected: Roger Kornberg, Phillip Frost, Fred Hassan, Anthony Japour, Richard Pfenniger, Steven Rubin.
- Weinberg & Company ratified as independent auditor for fiscal year ending December 31, 2024.
- Proposal to limit officer liability failed (4.85M for, 338K against; abstentions 26,484).
- Non-binding advisory vote on exec compensation approved; company will hold say-on-pay vote every three years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315224025598/0001493152-24-025598-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315224025598/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-025598

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer